Pulse pressure/stroke volume indexed to height 2.04 (PP/SVi) is a validated measure of arterial stiffness, but its relation to carotid atherosclerosis is unknown.
Increased arterial stiffness is a hallmark of vascular end-organ damage in hypertension. 1 Previous studies have documented that increased arterial stiffness, evaluated by carotid-femoral pulse wave velocity predicts cardiovascular (CV) mortality in general population as well as in groups with high CV risk, including elderly patients and patients with hypertension or diabetes. [1] [2] [3] [4] [5] Increased carotid-femoral pulse wave velocity has also been strongly associated with atherosclerosis, evaluated by larger common carotid intima-media thickness (IMT), presence of plaque in the carotid artery and in the aorta, and presence of clinical peripheral arterial disease. 6 In particular, higher pulse wave velocity has been associated with presence of more advanced fibrotic or calcified carotid plaques. 7 However, this association has not been clearly documented in hypertensive population.
Arterial stiffness is defined as the relationship between changes in arterial pressure per unit of change in arterial volume. 8 Stroke volume measured by echocardiography can be used as an estimate of arterial volume changes, and previous studies have demonstrated that pulse pressure/stroke index ratio (PP/SVi) is also a reproducible measure of arterial stiffness, 9 based on a 2-Windkessel model of arterial impedance. PP/SVi is associated with other markers of preclinical CV disease and predicts adverse CV events and mortality better than clinical blood pressure values and independently of left ventricular (LV) hypertrophy in hypertensive populations. 8, 10 However, though the prognostic value of arterial stiffness measured as PP/SVi is well documented, its independent relation with carotid atherosclerosis has not been demonstrated in the setting of arterial hypertension on epidemiological scale and using widely available methods. Accordingly, the present study was conceived to assess the relation between arterial stiffness, measured as PP/SVi, and presence of atherosclerosis (evaluated by severity of carotid IMT and presence of carotid plaque) in hypertensive patients without prevalent CV disease.
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Methods
Patient population. As previously reported, 11, 12 we have generated an open electronic registry from a network of 23 community hospital-based hypertension clinics and 60 general practitioners, referring to our Hypertension Center of the Federico II University Hospital of Naples (Italy), in the Campania District (the Campania Salute Network). This registry currently includes over 12,000 patients. Prevalent CV disease, defined as previous myocardial infarction, angina, coronary revascularization, stroke, transient ischemic attack, or congestive heart failure, has been evaluated by the Committee for Event Adjudication in the Hypertension Center, based on patient history and direct contact with the referring physician. 11, 12 By 2 May 2011, a total of 8,909 hypertensive patients without prevalent CV disease had been enrolled in the Campania Salute Network. Of these, 2,700 patients entered the registry before carotid ultrasound assessment was included in the Campania Salute Network standard protocol. Thus, 6,209 patients had undergone both echocardiography and carotid ultrasound, and comprise the current study population.
The database generation of the Campania Salute Network was approved by the Federico II University Hospital Ethic Committee. All patients signed written informed consent for the possibility of using the data for scientific purposes.
Office blood pressure was measured in triplets by regularly calibrated aneroid sphygmomanometers after at least 5 min of rest in the sitting position, following current guidelines. The average of the two last measurements was taken as the office blood pressure. Office pulse pressure was calculated as the difference between systolic and diastolic clinic blood pressure and mean blood pressure as 1/3 pulse pressure + diastolic blood pressure.
Hypercholesterolemia was defined as total cholesterol ≥240 mg/dl and hypertriglyceridemia as serum triglycerides ≥150 mg/dl. 13 Diabetes was defined as history of diabetes, use of any antidiabetic medication or having a fasting blood glucose ≥126 mg/dl. 14 Creatinine clearance (eCC) was estimated using the Cockcroft-Gault equation. 15 Carotid ultrasound. Carotid ultrasonography was performed using a commercially available ultrasound scanner equipped with a 7.5-MHz high-resolution transducer with an axial resolution of 0.1 nm. B-mode ultrasonography was performed with subjects in the supine position with the head turned away from the sonographer and the neck extended in mild rotation. Images were recorded on S-VHS tapes for offline analysis. The standardized comprehensive scanning and reading protocol has been previously published. 16 Data used for the present paper were obtained from two replicate ultrasound examinations of carotid artery IMT at 12 different carotid sites (i.e., right and left common and internal carotid arteries, near and far walls, distal common, bifurcation and proximal internal carotid artery), performed by certified sonographers. 16 Carotid ultrasound exams were reported on S-VHS videotapes, digitally transferred and then read by two expert readers. The average and the maximum IMT was reported in the individual patient, as measures of extension and severity of carotid atherosclerosis, respectively. Carotid plaque was defined as IMT ≥1.5 mm in accordance with previous studies. 17 In a separate series at the Hypertension Center, repeated scans and readings were used to estimate the intraobserver and interobserver reproducibility which was 0.01 and 0.03 mm on average, respectively, as previously reported. 16 Echocardiography. Echocardiography was performed using commercially available phased-array machines following a standardized protocol for imaging and offline reading. 12 Quantitative echocardiography was performed following the European Association of Echocardiography and American Society of Echocardiography guidelines. 18 LV hypertrophy was identified by prognostically validated gender-specific cutoff values. 19 Stroke volume was computed as the difference between end-diastolic and end-systolic volumes by the z-derived method, 20 and normalized for height in the power of 2.04 (SVi). 21 When optimal orientation of the M-mode cursor could not be obtained, correctly oriented linear dimension measurements were made using two-dimensional imaging from the parasternal long-axis view. 22 The ratio between supine pulse pressure, measured at the end of the echocardiographic examination, and SVi (PP/SVi) was used as a raw indicator of total arterial stiffness. 9, 10 Statistics. Data were analyzed using SPSS version 19.0 (IBM SPSS, Armonk, NY). The study population was divided into tertiles of PP/SVi. Continuous data are expressed as mean ± 1 s.d. and categorical variables as percentages. Normality was tested for all variables using Kolmogorov-Smirnov test. Variables deviating from normality (triglycerides) were log-transformed for use in parametric statistics. PP/SVi was categorized in tertiles, which were compared using ANOVA with Scheffe's posthoc test. Chi square statistics was used for categorical variables. The association between PP/SVi and IMT was tested in multivariate linear regression using the enter method with PP/SVi as a continuous variable and age, total cholesterol, triglycerides, diabetes, estimated eCC, brachial mean blood pressure, pulse pressure and gender as covariates. Results from multivariate linear regression are presented as multiple R 2 for the model and as standardized β-coefficient and level of significance for all independent covariates. The association between tertiles of PP/SVi and carotid plaque was tested estimating the prevalence ratios using log-binomial distribution in a generalized linear model 23 with age, diabetes, sex, and cholesterol as covariates. The effect of hypertensive medications and statins on the association between plaque and tertiles of PP/SVi, in addition to the other confounders, was evaluated using logistic regression. A P value <0.05 was considered statistical significant.
results
Systolic and diastolic blood pressure did not differ between included and excluded patients (145 ± 20 vs. 145 ± 18 mm Hg and 90 ± 12 vs. 89 ± 11 mm Hg, respectively), whereas excluded original contributions Arterial Stiffness and Carotid Atherosclerosis patients were slightly younger (50 ± 13 vs. 54 ± 11 years, P < 0.01), more likely to be women (45.6 vs. 42.9%, P < 0.05) and used on average a lower number of antihypertensive drugs (1.5 ± 1.1 vs. 1.9 ± 1.1, P < 0.01). Pulse pressure detected at the end of echocardiogram was 48 ± 8 mm Hg in the lowest tertile, 61 ± 8 mm Hg in the 2nd tertile (P < 0.01 vs. the other tertiles) and 77 ±13 mm Hg in the highest tertile (P < 0.01 vs. the other tertiles).
Age, systolic blood pressure and proportion of women increased in parallel with increasing PP/SVi tertile. The highest PP/SVi tertile also included more patients with diabetes mellitus, higher total serum cholesterol and lower eCC ( Table 1) . LV mass index decreased from the lower to the higher PP/SVi tertile, reflecting the increasing proportion of women ( Table 2) , and paralleling coherent changes in LV end-diastolic dimension and SVi. However, when adjusting for gender in a general Figure 1) . Compared to the lowest tertile of PP/SVi, after adjusting for age, sex, diabetes, and cholesterol levels, the multiple adjusted prevalence ratio of carotid plaque was seven in subjects in the 2nd tertile of PP/ SVi (95% confidence interval (CI): 1-13; P < 0.03) and 21 (95% CI: 15-28; P < 0.0001) in the highest tertile. In univariate correlations, using continuous variables, higher PP/SVi was weakly, but significantly associated with higher peak carotid IMT (r = 0.17) and mean carotid IMT (r = 0.20), (Figure 2 ) older age (r = 0.23), higher heart rate (r = 0.11), cholesterol (r = 0.10) and serum glucose (r = 0.08), lower serum creatinine (r = -0.09) and lower eCC (r = -0.19, all P < 0.001). Table 3 shows that greater IMT was confirmed to be independently related to higher PP/SVi (β = 0.06), also after accounting for significant confounders, including age, male gender, diabetes, mean blood pressure, pulse pressure, lipid profile and eCC, with low degree of variance inflation.
Adding antihypertensive classes of medications and statins as covariates in the model did not change the results, although all medications except β-blockers were associated with lower IMT (data not shown). Similarly, Table 4 shows that angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, calcium-channel blockers, diuretics and statins were significantly associated with lower IMT (all P < 0.05), whereas no significant association was found for α-or β-blockers.
discussion
The present study adds to current knowledge by demonstrating that in hypertensive patients without prevalent CV disease, participating in the Campania Salute Network, carotid IMT and prevalence of carotid plaque rise in parallel with increasing arterial stiffness measured as PP/SVi. Of note, carotid atherosclerosis was very common in these asymptomatic hypertensive patients, as >50% of patients in the lowest PP/SVi tertile also demonstrated carotid plaques. The finding is consistent with previous studies demonstrating a high prevalence of carotid atherosclerosis particularly in healthy middle-aged Southern-Italian populations. 24, 25 It is well known that aging is the dominant process increasing vascular stiffness and pulse pressure, despite the betweenpopulation variability of age-dependent changes. 26 In Eastern Finnish men, the overall prevalence of carotid atherosclerosis was 49%, rising from 14.1% at age 42 to 82% at age 60 or more. 27 A prevalence of carotid plaque of 57% has been reported in a mixed British population aged 56-77 year, 28 and of 84% in men ≥70 years in the Netherlands. 29 Consistent with these studies, also in the setting of the Campania Salute Network age was the strongest predictor of higher IMT and of presence of carotid plaques. In addition to the expected association with CV risk factors (diabetes and lipid profile), defining a phenotype at high-risk for carotid atherosclerosis, in our study also high PP/SVi, a raw but simple and widely obtainable marker of arterial stiffness, holds a clear, 
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Arterial Stiffness and Carotid Atherosclerosis independent relation with higher carotid IMT and presence of carotid plaques, independent of patient's age. It is particularly relevant that this association was also independent of pulse pressure, with low level of collinearity, suggesting that PP/SVi is a biomarker not interchangeable with the simple measure of pulse pressure.
In the Early Vascular Aging (EVA) study, a prospective 4-year follow-up study in healthy French population aged 59-71 years, in addition to age, systolic blood pressure was the second strongest determinant of both presence of carotid plaque and increased IMT. 30 Also in our study, higher blood pressure was associated with increased arterial stiffness, larger carotid IMT and higher prevalence of carotid plaque. However, the association of PP/SVi with carotid atherosclerosis was even independent of mean blood pressure, which was used in our analysis as a raw estimate of the steady component of arterial pressure, in addition to pulse pressure that can be considered the pulsatile component of arterial impedance.
Not surprisingly, in our study, also diabetes mellitus was an independent predictor of higher carotid IMT and presence of carotid plaques, confirming previous findings in clinical and epidemiological settings. 31 As demonstrated in our analysis, high PP/SVi paralleled increased IMT and presence of carotid plaques also independent of the expected association between lipid profile and carotid atherosclerosis. Previously, the EVA study 30 reported that hypercholesterolemia, defined as a total cholesterol level ≥7.2 mmol/l (280 mg/dl) or use of lipid-lowering drugs, was related to the presence of carotid plaque, whereas no association was found with IMT. 30 Our findings extend this association into hypertensive population free of prevalent CV events.
The extent of prescription of antihypertensive medications and statins was greater in patients with higher PP/SVi, reflecting the higher risk factor burden. The prescribed medications at the time of the admission of patients into the Campania Salute network program reflected the referring physician's choice in the individual patient. Although the cross-sectional nature of our analysis blunts identification of any causal relationship, in multivariate analysis the use of statins and any antihypertensive drug, except for β-and α-blockers, was independently associated with less carotid atherosclerosis, also independently of arterial stiffness. Thus, our findings support the notion that therapeutic interventions on blood pressure and hypercholesterolemia per sé improve target organ damage 32 and are consistent with findings from longitudinal studies, which demonstrated a beneficial effect from antihypertensive and lipid-lowering therapy on regression of atherosclerosis and reduction of CV events. [33] [34] [35] 
Potential limitations
Association between PP/SVi and carotid atherosclerosis was confirmed also after adjusting for gender. However, since proportion of women slightly increases with increasing PP/ SVi tertiles, while female gender confirms to have less severe carotid atherosclerosis, 36 future studies should address potential differences between men and women.
Pulse pressure was not measured centrally, and this might be a limitation of this study, due to the peripheral amplification of the pulsatile component of arterial impedance. However, the difference between central and peripheral pulse pressure is influenced by aging and we included age in all our multivariate analyses. Thus, in an epidemiological setting, brachial pulse pressure can provide valuable information and is probably the easiest obtainable, though crude, estimate of arterial stiffness.
In evaluating our findings, it should be also considered that PP/SVi ratio represents a static model of circulation based on 37, 38 which make the physic principle of "stiffness = force/displacement" not fully applicable to human circulation. However, there is evidence that all measures of arterial stiffness or compliance go to the same direction when applied to pathological conditions affecting the arterial tree 39, 40 and, therefore, PP/SVi ratio can be considered a good marker, and probably the most available, as it can be obtained everywhere it is possible to perform a quantitative echocardiogram. In hypertensive patients without known CV disease, increased arterial stiffness, measured as PP/SVi by echocardiography is associated with increased carotid IMT and presence of carotid atherosclerotic plaques, independent of demographic and clinical covariates.
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